Back
ESC Premium Access

Are your atrial fibrillation (AF) patients protected from ischaemic stroke? Clinical characteristics of AF patients eligible for stroke prevention but remaining untreated in UK clinical practice

Session: Poster session 3 - Anticoagulation in atrial fibrillation II
Topic: Atrial fibrillation (AF)
Speaker: Doctor E. Ridha (London, GB)
Event: ESC Congress 2016

Congress Presentation

Add to my library

Like

About the speaker

Doctor Essra Ridha

Bristol-Myers Squibb Pharmaceuticals Limited , London (United Kingdom of Great Britain & Northern Ireland)
0 follower

22 more presentations in this session

Is Aspirin monotherapy effective for stroke prevention in the real world? A UK cohort study evaluating the incidence of stroke in the absence of anticoagulation in atrial fibrillation (AF)

Speaker: Doctor E. Ridha (London, GB)

Access
Abstract
Slides
Like
Thumbnail

Poor anticoagulation control in warfarin treated atrial fibrillation patients with reduced renal function

Speaker: Doctor A. Nissen Bonde (Gentofte, DK)

Access
Abstract
Slides
Like
Thumbnail

In-hospital mortality, length of stay and costs of treating atrial fibrillation or flutter patients admitted for intracranial hemorrhage

Speaker: Doctor E. Nguyen (Storrs, US)

Access
Abstract
Slides
Like
Thumbnail

One-year permeability rate of left atrial appendage closure devices: high incidence of peridevice leak and lack of endothelialization

Speaker: Doctor G. Laugaudin (Montpellier, FR)

Access
Abstract
Like
Thumbnail

Net clinical benefit of rivaroxaban compared with warfarin in patients with atrial fibrillation

Speaker: Professor J. Piccini (Durham, US)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster session 3 - Anticoagulation in atrial fibrillation II

Speakers: Doctor E. Ridha, Doctor E. Ridha, Doctor A. Nissen Bonde, Doctor E. Nguyen, Doctor G. Laugaudin...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources